Metronidazole in Anaerobic Infections: A Review of its Activity, Pharmacokinetics and Therapeutic Use
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Synopsis: Metronidazole 1 which has been widely used for many years in the treatment of trichomoniasis, amoebiasis and giardiasis, has recently been shown to be active against anaerobic bacteria. Serum, cerebrospinal fluid and tissue concentrations bactericidal for Bacteroides species are attained after usual dosages given orally or intravenously or higher dosages given rectally (suppository). Prospective studies have demonstrated that the addition of metronidazole to regimens for pre-operative bowel preparation, decreases the frequency of postoperative infection and eliminates anaerobic infection. Similarly, anaerobic infection after acute appendicectomy or hysterectomy has been virtually eliminated by metronidazole given before and up to 1 week after surgery. Metronidazole has been successfully used in the treatment of anaerobic infections of the chest, head, gastrointestinal and female genitourinary tract, and of anaerobic septicaemia and bacteraemia.
Metronidazole is the most active agent available against obligate anaerobes and is likely to be of major value in the treatment of serious infections due to these organisms. Although the absence of formal comparative trials in many areas of use makes it difficult to clearly state the relative therapeutic efficacy of metronidazole, compared with other drugs such as clindamycin, chloramphenicol or penicillin, it is nevertheless a very effective agent in the treatment and prevention of anaerobic infections.
Antimicrobial Activity: Metronidazole, as well as other nitroimidazoles such as tinidazole, is active in vitro against obligate anaerobes, but has no clinically relevant activity against facultative anaerobes, obligate aerobes or microaerophilic bacteria other than Campylobacter fetus and H. (Corynebacterium) vaginalis. At concentrations readily attained in serum after oral, rectal or intravenous administration, metronidazole is active against Bacteroides fragilis, and B. melaninogenicus, Fusobacterium sp, Clostridium perfringens and other Clostridium species. However, it is generally less active against non-sporeforming Gram-positive bacilli such as Actinomyces sp, Propionibacterium sp, Bifidobacterium sp and Eubacterium sp; it is also somewhat less active against Gram-positive cocci (Peptostreptococcus and Peptococcus sp), but the less sensitive strains are usually not obligate anaerobes. Against susceptible organisms, metronidazole is generally bactericidal at concentrations equal to or slightly higher than the minimum inhibitory concentration.
The precise mode of action of metronidazole is not clear, but it appears that after entering the cell, the drug is reduced by some means and binds to desoxyribonucleic acid. Only susceptible bacteria appear to be capable of metabolising the drug.
Toxicology Studies: The toxicity of metronidazole during long term administration varies between strains of mice and different animal species, the dog exhibiting neurological disturbances not observed with other animal species. High oral dosages caused weight loss and testicular atrophy in one strain of mice and in rats, whilst intravenous metronidazole did not influence the rate of weight gain in rats or produce any significant changes in blood pressure or in haematological or biochemical values. Histological liver changes without associated changes in serum enzyme levels occurred in monkeys given high dosages.
Dosages of up to 1g/kg daily for 5 weeks did not produce a dominant lethal effect in the mouse. An increased incidence of lung tumours and malignant lymphoma have been reported in Swiss mice studied at one laboratory, but not in Sprague-Dawley rats or hamsters studied by other investigators. Further studies have failed to demonstrate that metronidazole induces unscheduled DNA synthesis or is mutagenic in male mice by the heritable translocation procedure.
A recent retrospective study conducted by the Mayo Clinic showed that the incidence of cancer in women who received metronidazole for T. vaginalis infections was not significantly different from that expected in that population, based on the observed number of cases in a larger population.
Pharmacokinetics: Metronidazole appears to be readily absorbed after oral administration. Peak serum concentrations are attained 1 to 3 hours after a single dose, but reported serum levels vary according to the assay method used. Microbiological assay has the advantage of indicating therapeutic activity but does not differentiate between the parent substance and some of its metabolites. After a single 250mg dose, peak serum concentration is about 5μg/ml, determined using GLC. The bioavailability of metronidazole does not appear to be significantly decreased by concomitant food ingestion.
Distribution studies in healthy human subjects and in patients, indicate that metronidazole readily penetrates into the cerebrospinal fluid and attains therapeutic concentrations in pus from cerebral abscesses and in empyema fluid. Metronidazole has a high apparent volume of distribution and is only slightly bound to serum proteins.
Metronidazole is eliminated in man largely by metabolism, resulting from side-chain oxidation, hydroxylation or conjugation of the parent compound. Over a period of 24 hours after oral administration of metronidazole, urinary recovery of total nitroderivatives accounts for 35 to 65 % of the dose when determined by chemical assay and for 15 to 20 % when bioassay is used. In the non-obstructed biliary tract, metronidazole is present in hepatic bile in concentrations similar to those found in serum and is concentrated in the normal gallbladder. The reported elimination half-life has varied between 6.2 and 11.5 hours in healthy subjects. The area under the serum concentration-time curve did not differ significantly in patients with normal or impaired renal function.
Metronidazole in Anaerobic Infections: Anaerobes are responsible for a variety of types of infection and are frequently found in clinical specimens from abdominal abscesses, peritonitis, thoracic empyema and in female genital tract infections. Although the distinction between isolates that are commensals or contaminants and those which are true pathogens may sometimes be difficult to make from routine specimens, it is established that anaerobes play a major role in postoperative infections related to the abdomen. Bacteroides species are frequently isolated from abdominal abscesses and wounds and in mixed culture in infections related to loss of integrity of the bowel mucosa and surgery of the female genital tract.
Metronidazole administered orally, rectally or intravenously has been successfully used to treat a wide range of intra-abdominal anaerobic infections, anaerobic infections resulting from surgery and trauma of the female genital tract, anaerobic chest infections, anaerobic infections of the head (brain abscess), peridontal infections, otitis media, infections of the bones and joints, and a few cases of anaerobic bacteraemia and endocarditis. In some instances the efficacy of metronidazole has been difficult to determine as it has been used in association with antibacterial agents active against aerobic and anaerobic bacteria. However, metronidazole has been effective in the treatment of septicaemia caused by anaerobic bacteria resistant to chloramphenicol and clindamycin, bacteraemia which has failed to respond to clindamycin, and endocarditis which has failed to respond to high dosages of benzylpenicillin plus streptomycin.
Metronidazole has been shown to be effective in anaerobic chest infections and anaerobic soft tissue pelvic infections in obstetrics and gynaecology, but it has not been compared in formal therapeutic trials with currently employed antimicrobial agents. Of the several agents available for the treatment of anaerobic pleuropulmonary infections, penicillin is the drug of choice, other than for B. fragilis infection. Whilst some authorities consider clindamycin to be the alternative of choice in penicillin sensitive patients because of the extent of documentation, others would prefer to use metronidazole.
In deep seated anaerobic pelvic infections metronidazole would be considered by workers in some parts of the world to be the drug of choice in preference to chloramphenicol and clindamycin, the current agents of choice in other countries.
As metronidazole penetrates readily into the CSF it is considered by some to be the agent of choice in place of chloramphenicol in the treatment of anaerobic meningitis, and on the basis of present data, it appears to be relatively non-toxic.
In B. fragilis endocarditis, metronidazole, because of its rapidly bactericidal action, may become the drug of choice and should probably be included in the antimicrobial regimen.
Prospective studies in patients undergoing elective colonic surgery have demonstrated that administration of metronidazole before, and for up to 7 days after surgery, in conjunction with other antimicrobial agents, significantly reduces the frequency of postoperative infection and eliminates non-sporing anaerobic infection. Wound infections caused by facultative organisms occurred in some patients treated with metronidazole, but generally less frequently than in those not so treated.
Administration of metronidazole 1 to 2g on admission and 200mg thrice daily for up to 7 days after surgery decreased the frequency of infections and virtually eliminated anaerobic infection after emergency appendicectomy or elective hysterectomy.
The indications for prophylactic antibiotics in elective bowel surgery are still debated, but results of studies using metronidazole in addition to kanamycin, neomycin or phthalylsulphathiazole provide strong evidence that anaerobic bacteria (particularly Bacteroides sp.) are the major contributors to intra-abdominal and wound infection after colon surgery.
Side Effects: Side effects have seldom been reported in patients treated with metronidazole for anaerobic infection. The use of higher than usual dosages has resulted in occasional instances of parasthesiae of the feet and hands, peripheral neuropathy and epileptiform seizures. Further studies are needed to determine the frequency and nature of adverse effects likely to be encountered with the higher dosages and greater duration of metronidazole treatment sometimes necessary for the treatment of severe anaerobic infections.
Dosage: In the treatment of anaerobic infections, the usual adult oral dosage is 400mg* 3 times daily for 7 days or longer according to the clinical response. The oral dosage in infants and children is 7.5mg/kg 3 times daily. If rectal suppositories are to be used, adults should receive 1g 3 times daily for 3 days and then 12-hourly for 4 days, the corresponding children’s (5 to 12 years) dose being 0.5g administered as for adults. Younger children should receive 250mg doses for 1 to 5 year olds and 125mg doses for those under 1 year. Oral medication should be resumed as soon as possible.
By intravenous infusion, the usual dosage for adults is 500mg in 100ml solution 8-hourly,† administered at a rate of 5ml per minute. For children under 12 years the intravenous dosage is 7.5mg/kg infused as for adults.
In the prevention of anaerobic infection in gynaecological surgery, 1g orally as a single dose followed when possible by 200mg orally, 3 times daily for up to 7 days after surgery is the recommended regimen. In elective colonic surgery, metronidazole has been successfully used when given alone (1 g orally as single dose, 200mg 8 hourly thereafter when possible and 1 g rectally 8 hourly during periods when oral medication is not possible, for a total of 7 days treatment) and when given concomitantly with kanamycin or phthalylsulphathiazole (see section 10.2).
- Alexander-Williams, J, McLeish, AR, Keighley, KRB, Burdon, DW (1976) Prophylactic antibiotics in bowel surgery. Proceedings of the Royal Society of Medicine 69: pp. 327
- Altemeier, WA, Culbertson, WR, Fullen, WD, Shook, CD (1973) Intra-abdominal abscesses. American Journal of Surgery 125: pp. 70
- Amon, I, Amon, K, Huiler, H (1977) Pharmakokinetik von metronidazol wahrend der kurztherapie der trichomoniasis urogenitalas. Zentralblatt fur Gynakologie 99: pp. 1180
- Amon, I, Amon, K, Huiler, H (1978) Pharmacokinetics and therapeutic efficacy of metronidazole at different dosages. International Journal of Clinical Pharmacology 16: pp. 384
- Back, E, Hermanson, J, Wickman, M (1978) Metronidazole treatment of liver abscess due to Bacteroides fragilis. Scandinavian Journal of Infectious Diseases 10: pp. 152
- Bannatyne, R-M, Harnett, NM (1976) Metronidazole and acne. Acta dermato-venereologica (Stockholm) 56: pp. 307-308
- Baron, D, Drugeon, H, Nicolas, F, Courtieu, AL (1975) The use of metronidazole in septicaemia due to Bacteroides fragilis. Two observations. Nouvelle Presse Medicale 4: pp. 667
- Baron, D, Drugeon, H, Nicolas, F, Courtieu, AL (1977) Les infections severes a Bacteroides fragilis: Traitement par le metronidazole. Donnees cliniques et pharmacologiques. Medecine et Maladies Infectieuses 7: pp. 158
- Bartlett, JG Head and neck, bone and joint, and chest infections, bacteraemia and endocarditis due to non-sporeforming anaerobes. In: Phillips, , Sussman, eds. (1974) Infection with Non-sporing Anaerobic Bacteria. pp. 131
- Bartlett, JG, Chang, TW, Onderdonk, AB (1978) Will the real Clostridium species responsible for antibiotic-associated colitis please step forward. Lancet 1: pp. 338
- Bartlett, JG, Gorbach, SL, Finegold, SM (1974) The bacteriology of aspiration pneumonia. American Journal of Medicine 56: pp. 202
- Bartlett, JG, Gorbach, SL, Tally, FP, Finegold, SM (1974) Bacteriology and treatment of lung abscess. American Review of Respiratory Diseases 109: pp. 510
- Bartlett, JG, Gorbach, SL, Thadepalli, H, Finegold, SM (1974) Bacteriology of empyema. Lancet 1: pp. 338
- Bartlett, JG, Onderdonk, AB, Drude, E, Goldstein, C, Anderka, M, Alpert, S, McCormack, WM (1977) Quantitative bacteriology of the vaginal flora. Journal of Infectious Diseases 136: pp. 271
- Beard, C.M.; Nolier, K.L.; O’Fallon, W.M. and Kurland, L.T.: Is metronidazole (‘Flagyl’) carcinogenic in humans. Paper presented at the Preventative Oncology Meeting, Washington, D.C. March 1978.
- Bittner, J, Ardeleanu, J Preventative action of metronidazole on experimental C. perfringens induced gas gangrene in guinea pigs. In: Finegold, eds. (1977) Metronidazole. pp. 329
- Bittner, J, Munteanu, V Potentiating action of combining metronidazole and penicillin against C. perfringens in vitro;. In: Finegold, eds. (1977) Metronidazole. pp. 293
- Bost, RG Metronidazole: Toxicology and teratology. In: Finegold, eds. (1977) Metronidazole. pp. 112
- Bost, RG Metronidazole: Mammalian mutagenicity. In: Finegold, eds. (1977) Metronidazole. pp. 126
- Bradnum, P, Hood, FJC (1977) Metronidazole in the treatment of severe acute pericoronitis. Brit. Dent. J. 142: pp. 313
- Brass, C, Richards, GK, Ruedy, J, Prentis, J, Hinchey, EJ (1978) The effect of metronidazole on the incidence of postoperative wound infection in elective colon surgery. American Journal of Surgery 135: pp. 91
- Busch, DF, Sutter, VL, Finegold, SM (1976) Activity of combinations of antimicrobial agents against Bacteroides fragilis. Journal of Infectious Diseases 133: pp. 321
- Cella, PL (1969) Experimental studies on the teratology on metronidazole. Rivista di Patologia e Clinica 24: pp. 529
- Cerat, GA, Cerat, LL, McHenry, MC, Wagner, JG, Hall, PM, Gavan, TL (1977) Metronidazole in renal failure. Finegold. pp. 404
- Chattopadhyay, B (1977) Bacteroides fragilis meningitis. Lancet 1: pp. 1371
- Chien, YW, Mizuba, SS (1978) Activity-electroreduction relationship of antimicrobial metronidazole analogues. Journal of Medicinal Chemistry 21: pp. 374
- Chow, A.W.; Bendnorz, D. and Guze, L.B.: Susceptibility of obligate anaerobes to metronidazole: An extended study of 1,054 clinical isolates; in Finegold (Ed) Metronidazole. Proceedings of the International Metronidazole Conference, Montreal, May 1976, p.286 (Excerpta Medica, 1977).
- Chow, AW, Patten, V, Bendnorz, D (1978) Susceptibility of Campylobacter fetus to twenty-two antimicrobial agents. Antimicrobial Agents and Chemotherapy 13: pp. 416
- Chow, AW, Patten, V, Guze, LB (1975) Susceptibility of anaerobic bacteria to metronidazole: Relative resistance of non-spore-forming Gram-positive bacilli. Journal of Infectious Diseases 131: pp. 182
- Churcher, GM, Human, RP (1977) Assessment of the in vitro activity against Bacteroides spp. of spectinomycin, metronidazole and clindamycin. Journal of Antimicrobial Chemotherapy 3: pp. 363
- Cohen, SM, Enturk, E, Esch, AM, Crovetti, AJ, Bryan, GT (1973) Carcinogenicity of 5-nitrofurans, 5-nitroimidazoles, 4-nitrobenzenes and related compounds. Journal of the National Cancer Institute 51: pp. 403
- Corrodi, P, Busch, DF, Sutter, VL, Wideman, PA, Citronbaum, DM, Finegold, SM Factors affecting the in vitro antibacterial activity of metronidazole. In: Finegold, eds. (1977) Metronidazole. pp. 299
- Davies, AH (1967) Metronidazole in human infections with syphilis. British Journal of Venereal Diseases 43: pp. 197
- De Carneri, I.; Cantone, A.; Emanueli, A.; Giraldi, P.N.; Logemann, W.; Meinardi, G.; Monti, G.; Nannini, G.; Tosolini, G. and Vita, G.: Nitrimidazine: a new trichonomacide. Paper presented at 6th International Congress of Chemotherapy, Tokyo, August 1969.
- Dornbusch, K, Nord, C-E, Dahlback, A (1975) Antibiotic susceptibility of Clostridium species isolated from human infections. Scandinavian Journal of Infectious Diseases 7: pp. 127-134
- Dornbusch, K, Nord, C-E, Olsson, B (1975) Antibiotic susceptibility testing of anaerobic bacteria by the standardised disc diffusion method with special reference to Bacteroides fragil is. Scandinavian Journal of Infectious Diseases 7: pp. 59
- Dornbusch, K, Nord, C-E, Wadstrom, T (1974) Biochemical characterisation and in vitro determination of antibiotic susceptibility of clinical isolates of Bacteroides fragil is. Scandinavian Journal of Infectious Diseases 6: pp. 253
- Douglas-Smith, BJ, Wellingham, J (1976) Metronidazole in treatment of empyema. Brit. med. J. 1: pp. 1074-1075
- Dublanchet, A, Durieux, R, Fevre, D (1977) Sensibilite des bacteries anaerobies au metronidazole. Medicine et Maladies Infectieuses 7: pp. 317
- Edwards, DI (1977) The action of metronidazole on DNA. Journal of Antimicrobial Chemotherapy 3: pp. 43
- Edwards, DI, Dye, M, Carne, H (1973) The selective toxicity of antimicrobial nitroheterocyclic drugs. Journal of General Microbiology 76: pp. 135
- Edwards, DI, Knight, RC, Kantor, I Interaction of nitroimidazole drugs with DNA. In: Siegenthaler, a, Luthy, eds. (1978) Current Chemotherapy. American Society for Microbiology, Washington DC, pp. 714-716
- Eykyn, SJ, Phillips, I (1976) Metronidazole and anaerobic sepsis. British Medical Journal 2: pp. 1418
- Eykyn, S, Phillips, I Intravenous metronidazole in the treatment of anaerobic sepsis. In: Finegold, eds. (1977) Metronidazole. pp. 393
- Feathers, RS, Lewis, AAM, Sagor, GR, Amirak, ID, Noone, P (1977) Prophylactic systemic antibiotics in colorectal surgery. Lancet 2: pp. 4
- Feldman, WE (1976) Bacteroides fragilis ventriculitis and meningitis. Report of two cases. American Journal of Diseases of Children 130: pp. 880-883
- Feiner, JM, Dowell, VR (1970) Anaerobic bacterial endocarditis. New England Journal of Medicine 283: pp. 1188
- Ferguson, IR The assay of metronidazole. In: Finegold, eds. (1977) Metronidazole. pp. 23
- Finegold, SM Intra-abdominal, genitourinary, skin and soft tissue infections due to non-sporeforming anaerobic bacteria. In: Phillips, , Sussman, eds. (1974) Infection with Non-sporing Anaerobic Bacteria. pp. 160
- Finegold, SM, Sutter, VL Antimicrobial susceptibility of anaerobic Gram-negative bacilli. In: McPhee, eds. (1972) Host Resistance to Commensal Bacteria. pp. 275
- Freeman, WA, McFadzean, JA, Whelan, JPF (1968) Activity of metronidazole against experimental tetanus and gas gangrene. Journal of Applied Bacteriology 31: pp. 443
- Frytak, S, Moertel, CG, Childs, DS, Schutt, AJ, Albers, JW (1978) Phase II study of metronidazole therapy for advanced colorectal carcinoma. Cancer Treatment Reports 62: pp. 483
- Fuzi, M, Csukas, Z (1970) Das antibakterielle wirkungs spektrum des metronidazols. Infektions krankheiten und Hygiene. I. Abt Medizinisch-Hygienische virus forschung und Parasitologie Originale 213: pp. 258
- Galgiani, JN, Busch, DF, Brass, C, Rumans, LW, Mangels, JI, Stevens, DA (1978) Bacteroides fragilis endocarditis, bac-teremia and other infections treated with oral or intravenous metronidazole. American Journal of Medicine 65: pp. 284
- Garcia Rodriguez, JA, Garcia Sanchez, JE, Saenz Gonzalez, MC, Prieto Prieto, J (1977) The sensitivity of anaerobic Gram-negative bacilli to four nitroimidazole derivatives. Phar-matherapeutica 1: pp. 573
- George, RH, Bint, AJ (1976) Treatment of a brain abscess due to Bacteroides fragilis with metronidazole. Journal of Antimicrobial Chemotherapy 2: pp. 101
- George, RH, Symonds, JM, Dimock, F, Brown, JD, Arabi, Y, Shinagawa, N, Keighley, MRB, Alexander-Williams, J, Burdon, DW (1978) Identification of Clostridium difficile as a cause of pseudomembranous colitis. British Medical Journal 1: pp. 695
- Giamarellou, H, Kanellakopoulos, K, Pragastic, D (1977) Treatment with metronidazole of 48 patients with serious anaerobic infections. Journal of Antimicrobial Chemotherapy 3: pp. 347
- Gillespie, G, McNaught, W Prophylactic oral metronidazole in intestinal surgery. In: Finegold, eds. (1977) Metronidazole. pp. 385
- Goldring, J, McNaught, W, Scott, A, Gillespie, G (1975) Prophylactic oral antimicrobial agents in elective colonic surgery. A controlled trial. Lancet 2: pp. 997
- Gray, MS, Kane, PO, Squires, S (1961) Further observations on metronidazole. British Journal of Venereal Diseases 37: pp. 278
- Hale, JE, Perinpanayagam, RM, Smith, G (1976) Bacteroides: An unusual cause of breast abscess. Lancet 2: pp. 70
- Holdstock, DJ (1975) Drug treatment in Crohn’s disease. Lancet 2: pp. 1260
- Houghton, G.W.; Smith, J. and Thorne, P.S.: Comparison of the pharmacokinetics of metronidazole and its metabolites 14041 RP and 20396 RP in healthy female volunteers following either a single oral or intravenous dose (500mg) of ‘Flagyl’. Unpublished data, May and Baker, 1978.
- Hunt, W.L.; Agre, K.; Opperman, J. and Nissen, C.H.: Flagyl (metronidazole) in the treatment of anaerobic infections. Abstract of Paper presented at Meeting of American Society of Microbiology, May 1978.
- Hutchinson, M.; Lambert, H.P.; Loughman, D. and Morgan, M.W.E.: Metronidazole in experimental peritonitis; in Finegold (Ed) Metronidazole. Proceedings of the International Metronidazole Conference, Montreal, May 1976, p.320 (Excerpta Medica, 1977).
- Ingham, HR, Eaton, S, Venables, CW, Adams, PC (1978) Bacteroides fragilis resistant to metronidazole after long-term therapy. Lancet 1: pp. 214
- Ingham, HR, Hood, FJC, Bradnum, P, Tharogonnet, D, Selkon, JB (1977) Metronidazole compared wth penicillin in the treatment of acute dental infections. British Journal of Oral Surgery 14: pp. 264
- Ingham, HR, Rich, GE, Selkon, JB, Hale, JH, Roxby, CM, Betty, MJ, Johnson, RWG, Uldall, PR (1975) Treatment with metronidzole of three patients with serious infections due to Bacteroides fragilis. Journal of Antimicrobial Chemotherapy 1: pp. 235
- Ingham, HR, Selkon, JB, Hale, JH (1975) The antibacterial activity of metronidazole. Journal of Antimicrobial Chemotherapy 1: pp. 355
- Ingham, HR, Sisson, PR, Tharogonnet, D, Selkon, JB, Codd, AA (1977) Inhibition of phagocytosis in vitro by obligate anaerobes. Lancet 2: pp. 1252
- Ingham, HR, Selkon, JB, Roxby, CM (1977) Bacteriological study of otogenic cerebral abscesses: chemotherapeutic role of metronidazole. British Medical Journal 2: pp. 991
- Ings, RMJ, McFadzean, JA, Ormerod, WE (1974) The mode of action of metronidazole in Trichomonas vaginalis and other micro-organisms. Biochem. Pharmacol. 23: pp. 1421
- Ings, RMJ, McFadzean, JA, Ormerod, WE (1975) The fate of metronidazole and its implications in chemotherapy. Xenobiotica 5: pp. 223
- Jokipii, AMM, Karma, P, Ojala, K, Jokipii, L (1977) Anaerobic bacteria in chronic otitis media. Archives of Otolaryngology 103: pp. 278
- Jokipii, L, Jokipii, AMM (1977) Bactericidal activity of metronidazole, tinidazole and ornidazole against Bacteroides fragilis in vitro. Journal of Antimicrobial Chemotherapy 3: pp. 571
- Jones, PH, Willis, AT, Ferguson, IR (1978) Treatment of anaerobically infected pressure sores with topical metronidazole. Lancet 1: pp. 214
- Jorgenson, T.A. and Rushbrook, C.J.: Heritable translocation study of metronidazole. Stanford Research Institute. Unpublished data (1977).
- Krazmier, FJ (1976) A significant interaction between metronidazole and warfarin. Mayo Clinic Proceedings 51: pp. 782
- Russo, NF, Lindmark, DG, Muller, M (1976) Hepatic metabolism and biliary excretion of metronidazole. Gastroenterology 70: pp. A47/905
- Russo, NF, Tomasz, M, Kaplan, D, Muller, M (1978) Absence of strand breaks in deoxyribonucleic acid treated with metronidazole. Antimicrobial Agents and Chemotherapy 13: pp. 19
- Russo, NF, Tomasz, M, Muller, M, Lipman, R (1977) Interaction of metronidazole with nucleic acid in vitro. Molecular Pharmacology 13: pp. 872
- Laufer, J, Mignon, H, Videau, D (1973) L’association metronidazole-spiramycine: Concentrations et synergie in situ comparees aux CMI de la flore buccale. Revue de Stomatologie 74: pp. 387
- Ledger, WJ, Gee, CL, Pollin, PA, Lewis, WP, Sutter, VL, Finegold, SM (1976) A new approach to patients with suspected anaerobic postpartum pelvic infections. Transabdominal uterine aspiration for culture and metronidazole for treatment Am. J. Obstet. Gynae. 126: pp. 1
- Ledger, WJ, Lewis, W, Golde, S, Gee, C The use of metronidazole in obstetric and gynecologic infections. In: Finegold, eds. (1977) Metronidazole. pp. 353
- Lefebvre, Y, Hesseltine, HC (1965) The peripheral white blood cells and metronidazole. Journal of the American Medical Association 191: pp. 15
- Lehmann, HE, Ban, TA (1967) Chemical reduction of compulsion to drink with metronidazole: new treatment modality in therapeutic program of alcoholic. Current Therapeutic Research 9: pp. 419
- Lerner, PI (1969) Penetration of cephalothin and lincomycin into the cerebrospinal fluid. American Journal of the Medical Sciences 257: pp. 125
- Levison, ME (1974) Microbiological agar diffusion assay for metronidazole concentrations in serum. Antimicrobial Agents and Chemotherapy 5: pp. 466
- Long, S.; Mueller, S. and Swenson, R.M.: Antibiotic susceptibilities of subspecies of Bacteroides fragilis. Paper presented at the 15th Interscience Conference of Antimicrobial Agents and Chemotherapy, Washington Sept 1975.
- McGilveray, IJ, Midha, KK, Loo, JCK, Cooper, JK (1978) The bioavailability of commercial metronidazole formulations. International Journal of Clinical Pharmacology 16: pp. 110
- McGowan, DA, Murphy, KJ, Shieham, A (1977) Metronidazole in the treatment of severe acute pericoronitis. A clinical trial. British Dental Journal 142: pp. 221
- Mee, WM Metronidazole prophylaxis and primary wound closure in appendicectomy. In: Willis, , Leigh, a, Hamilton-Miller, eds. (1978) Symposium on Management of Non-clostridial Anaerobic Infections. Journal of Antimicrobial Chemotherapy.
- Melander, A, Kahlmeter, G, Kamane, C, Ursing, B (1977) Bioavailability of metronidazole in fasting and non-fasting healthy subjects and in patients with Crohn’s disease. European Journal of Clinical Pharmacology 12: pp. 69
- Mitchell, A.D.: Unscheduled DNA synthesis testing of metronidazole. Stanford Research Institute, Unpublished data (1976).
- Mitre, RJ, Rotheram, EB (1974) Anaerobic septicemia from thrombophlebitis of the internal jugular vein. Successful treatment with metronidazole. Journal of the American Medical Association 230: pp. 1168
- Monro, AM (1974) Blood levels of chemotherapeutic drugs and the pharmacokinetics of tinidazole and metronidazole. Current Therapeutic Research and Opinion 2: pp. 130
- Morgan, JR, Smith, JA, Liu, P (1977) Improving the performance of anaerobic bacteriology in a hospital laboratory. Journal of Clinical Pathology 30: pp. 157
- Muller, M. and Lindmark, D.G.: Effect of oxygen on the uptake of metronidazole by trichomonads and Clostridium pasteurianum. Abstract of Paper Presented at the 15th Inter-science Conference on Antimicrobial Agents and Chemotherapy, Washington, Sept, 1975.
- Muller, M, Lindmark, DG, McLaughlin, J Mode of action of metronidazole on anaerobic microorganisms. In: Finegold, eds. (1977) Metronidazole. pp. 12
- Naik, RPC, Singh, G (1977) Fixed drug-eruption due to metronidazole. Dermatologica 155: pp. 59
- Nastro, LJ, Finegold, SM (1972) Bactericidal activity of five antimicrobial agents. Journal of Infectious Diseases 126: pp. 104
- Nielsen, ML, Justesen, T (1977) Excretion of metronidazole in human bile. Scandinavian Journal of Gastroenterology 12: pp. 1003
- O’Brien, RW, Morris, JG (1972) Effect of metronidazole on hydrogen production by Clostridium acetobutylicum.Arch. Mikrobiol. 81: pp. 225
- Oderdonk, AB, Hermos, JA, Dzink, JL, Bartlett, JG (1978) Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology 74: pp. 521
- O’Grady, LR, Ralph, ED (1976) Anaerobic meningitis and bacteremia caused by Fusobacterium species. American Journal of Diseases of Childhood 130: pp. 871
- Oppermann, J.; Azarnoff, D.; Hunt, W.; Shierk, D.; Muir, R. and Ranney, R.: Pharmacokinetics of intravenously administered 14C-metronidazole hydrochloride in man. Abstract of paper presented at meeting of American Society of Microbiology, May, 1978.
- O’Reilly, RA (1976) The stereoselective interaction of warfarin and metronidazole in man. New England Journal of Medicine 295: pp. 354
- Pheifer, TA, Forsyth, PS, Durfee, MA, Pollock, HM, Holmes, KK (1978) Nonspecific vaginitis. Role of haemophilus vaginalis and treatment with metronidazole. New England Journal of Medicine 298: pp. 1429
- Pieron, R, Debure, A, Mafart, Y, Lesobre, B, Bryskier, A, Vergez, P (1977) Traitement d’une pleuresie purulente anaerobie par injections locales de metronidazole. Semaine des Hopitaux 53: pp. 1709
- Pieron, R, Meyniel, D, Mafart, Y, Bryskier, A, Vergez, P (1977) Un cas de septicemie a clostridium subterminale avec localisations articulaires. Traitement par le metronidazole. Medicine et Maladies Infectieuses 7: pp. 270
- Plant, CW, Edwards, DI (1976) The effect of tinidazole, metronidazole and nitrofurazone on nucleic acid synthesis in Clostridium bifermentans. Journal of Antimicrobials and Chemotherapy 2: pp. 203
- Ralph, ED (1978) The bactericidal activity of nitrofurantoin and metronidazole against anaerobic bacteria. Journal of Antimicrobial Chemotherapy 4: pp. 177
- Ralph, E.D. and Kirby, W.M.M.: Unique bactericidal action of metronidazole against B. fragilis and C. perfringens. 15th Intersci. Conf. Antimicrob. Ag. Chemother., 24–26th September, 1975a, Washington, DC.Abstr. 382.
- Ralph, ED, Kirby, WMM (1975) Bioassay of metronidazole with either anaerobic or aerobic incubation. Journal of Infectious Diseases 132: pp. 587
- Ralph, E.D. and Kirby, W.M.M.: Human pharmacology of oral metronidazole as determined by bioassay; in Finegold (Ed) Metronidazole. Proceedings of the International Metronidazole Conference, Montreal, May 1976, p.50 (Excerpta Medica, 1977).
- Ralph, ED, Clarke, JT, Libke, RD, Luthy, RP, Kirby, WMM (1974) Pharmacokinetics of metronidazole as determined by bioassay. Antimicrobial Agents and Chemotherapy 6: pp. 691
- Reynolds, AV, Hamilton-Miller, JMT, Brumfitt, W (1975) A comparison of the in vitro activity of metronidazole, tinidazole, and nimorazole against Gram-negative anaerobic bacilli. Journal of Clinical Pathology 28: pp. 775
- Roe, FJC Metronidazole: Tumorigenicity studies in mice, rats and hamsters. In: Finegold, eds. (1977) Metronidazole. pp. 132
- Roe, FJC (1977) Metronidazole: a review of uses and toxicity. Journal of Antimicrobial Chemotherapy 3: pp. 205
- Rom, S, Flynn, D, Noone, P (1977) Anaerobic infection in a neonate. Early detection by gas liquid chromatography and response to metronidazole. Arch. Dis. Child. 52: pp. 740
- Rosenkranz, H.S. and Speck, W.T.: Studies on the significance of the mutagenicity of metronidazole for Salmonella typhimurium; in Finegold (Ed) Metronidazole. Proceedings of the International Metronidazole Conference, Montreal, May 1976, p.119 (Excerpta Medica, 1977).
- Rothstein, E, Clancy, DD (1969) Toxicity of disulfiram combined with metronidazole. The New England Journal of Medicine 280: pp. 1006
- Rothstein, E, Clancy, DD (1969) Disulfiram-metronidazole. New England Journal of Medicine 281: pp. 331
- Rust, JH An assessment of metronidazole tumorigenicity: Studies in the mouse and rat. In: Finegold, eds. (1977) Metronidazole. pp. 138
- Rustia, M, Shubik, P (1972) Induction of lung tumors and malignant lymphomas in mice by metronidazole. Journal of the National Cancer Institute 48: pp. 721
- Salem, AR, Jackson, DD, McFadzean, JA (1975) An investigation of interactions between metronidazole (Flagyl) and other antibacterial agents. Journal of Antimicrobial Chemotherapy 1: pp. 387
- Santoro, J, Kaye, D, Levison, ME (1976) In vitro activity of josamycin and rosamycin against Bacteroides fragilis compared with clindamycin, erythromycin and metronidazole. Antimicrobial Agents and Chemotherapy 10: pp. 188
- Schwartz, DE, Jeunet, F (1976) Comparative pharmacokinetic studies of ornidazole and metronidazole in man. Chemotherapy (Basel) 22: pp. 19
- Seggie, J (1978) Fusobacterium endocarditis treated with metronidazole. British Medical Journal 1: pp. 960
- Selkon, JB, Hale, JH, Ingham, HR Metronidazole in the treatment of anaerobic infection in man. In: Williams, a, Geddes, eds. (1976) Chemotherapy. pp. 277
- Semb, LS, Dyrstad, A, Johnsrud, M-L, Grabner, PJ, Viddal, KO (1977) A double blind study of metronidazole in preoperative treatment before colorectal surgery. Scandinavian Journal of Gastroenterology 12: pp. 94
- Sharp, DJ, Corringham, RET, Nye, EB, Sagor, GR, Noone, P (1977) Successful treatment of Bacteroides bacteraemia with metronidazole, after failure with clindamycin and lincomycin. Journal of Antimicrobial Chemotherapy 3: pp. 233
- Shinn, DL Vincent’s Disease and its Treatment. In: Finegold, eds. (1977) Metronidazole. pp. 334
- Sisson, PR, Ingham, HR, Selkon, JB (1978) A study of carbon dioxide-dependent strains of Streptococcus milled. Journal of Medical Microbiology 11: pp. 111
- Smith, H (1974) Anaerobic infections: a review. Current Medical Research and Opinion 2: pp. 109
- Sonnenwirth, AC Incidence of intestinal anaerobes in blood cultures. In: Balows, , Haan, , Dowell, , Guze, eds. (1974) Anaerobic Bacteria: Role in disease. Charles C. Thomas, Illinoispp. 157
- Stambaugh, JE, Feo, LG, Manthei, RW (1968) The isolation and identification of the urinary oxidative metabolites of metronidazole in man. Journal of Pharmacology and Experimental Therapeutics 161: pp. 373
- Staneck, JL, Washington, JA (1974) Antimicrobial susceptibilities of anaerobic bacteria: Recent clinical isolates. Antimicrobial Agents and Chemotherapy 6: pp. 311
- Stratford, B.C. and Dixson, S.: Intestinal asepsis with metronidazole, framycetin, and ampicillin. A preliminary report on 20 patients; in Siegenthaler and Luthy (Eds) Current Chemotherapy, Proceedings of the 10th International Congress of Chemotherapy, Vol. 2, p.270–272 (American Society for Microbiology, Washington 1978).
- Study, G (1975) An evaluation of metronidazole in the prophylaxis and treatment of anaerobic infections in surgical patients. Journal of Antimicrobial Chemotherapy 1: pp. 393
- Sutter, VL, Finegold, SM (1975) Susceptibility of anaerobic bacteria to carbenicillin, cefoxitin and related drugs. Journal of Infectious Diseases 131: pp. 417
- Sutter, VL, Finegold, SM (1976) Susceptibility of anaerobic bacteria for 23 antimicrobial agents. Antimicrobial Agents and Chemotherapy 10: pp. 736
- Sutter, V.L. and Finegold, S.M.: In vitro studies with metronidazole against anaerobic bacteria; In Finegold (Ed) Metronidazole. Proceedings of the International Metronidazole Conference, Montreal, May 1976, p.279 (Excerpta Medica 1977).
- Swenson, RM, Michaelson, TC, Daly, MJ, Spaulding, EH (1973) Anaerobic bacterial infections of the female genital tract. Obstetrics and Gynecology 42: pp. 538
- Tabaqchali, S Ecology and metabolic activity of non-sporing anaerobes. In: Phillips, a, Sussman, eds. (1974) Infection with Non-sporing Bacteria. pp. 59
- Takazoe, I, Qkuda, K, Yamamoto, A, Nakamura, T (1973) The effect of metronidazole on the experimental mixed infection of oral anaerobes. Bulletin of Tokyo Dental College 14: pp. 1-4
- Tally, FP, Sutter, VL, Finegold, SM (1972) Metronidazole versus anaerobes — in vitro data and initial clinical observations. California Medicine 117: pp. 22
- Tally, FP, Sutter, VL, Finegold, SM (1975) Treatment of anaerobic infections with metronidazole. Antimicrobial Agents and Chemotherapy 7: pp. 672
- Tally, FP, Sutter, VL, Armfield, AY, Dowell, VR, Kwok, YY, Finegold, SM (1974) Susceptibility of Clostridium ramosum to antimicrobial agents. Antimicrobial Agents and Chemotherapy 5: pp. 589
- Tally, FP, Goldin, BR, Sullivan, N, Johnston, J, Gorbach, SL (1978) Antimicrobial activity of metronidazole in anaerobic bacteria. Antimicrobial Agents and Chemotherapy 13: pp. 460
- Taylor, SA, Cawdery, HM (1977) The use of metronidazole in the preparation of the bowel for surgery. Proceedings of the Royal Society of Medicine 70: pp. 481
- Ueno, K, Ninomiya, K, Suzuki, S (1971) Antibacterial activity of metronidazole against anaerobic bacteria. Chemotherapy (Tokyo) 19: pp. 111
- Ueno, K.: Antibacterial action of metronidazole (‘Flagyl’) against anaerobes in vivo. Unpublished data.
- Ursing, B, Kamme, C (1975) Metronidazole for Crohn’s disease. Lancet 1: pp. 775-777
- Warner, JF, Prior, RB Clinical and in vitro studies of the bactericidal activity of metronidazole against anaerobic bacteria. In: Finegold, eds. (1977) Metronidazole. pp. 359
- Washington, JA (1971) Comparison of two commercially available media for detection of bacteraemia. Applied Microbiology 22: pp. 604
- Watt, B, Jack, EP (1977) What are anaerobic cocci?. Journal of Medical Microbiology 10: pp. 462
- Watt, B, Jack, EP Susceptibility of anaerobic cocci to imidazole derivatives with special reference to metronidazole and sulnidazole. In: Siegenthaler, a, Luthy, eds. (1978) Current Chemotherapy. American Society for Microbiology, Washingtonpp. 716
- Webb, CH (1977) Mismanaged facial infection. Lancet 2: pp. 511
- Weinstein, L, Rubin, RH (1973) Infective endocarditis. Progress in Cardiovascular Disease 16: pp. 239
- Welling, PG, Monro, AM (1972) The pharmacokinetics of metronidazole and tinidazole in man. Arzneimittel Forschung 22: pp. 2129
- Wheeler, LA, Meo, M, Halula, M, George, L, Heseltine, P (1978) Use of high-pressure liquid chromatography to determine plasma levels of metronidazole and metabolites after intravenous administration. Antimicrobial Agents and Chemotherapy 13: pp. 205
- Wheeler, LA, Meo, M, Halula, M, George, L, Heseltine, P (1978) Use of high-pressure liquid chromatography to determine plasma levels of metronidazole and metabolites after intravenous administration. Antimicrobial Agents and Chemotherapy 13: pp. 205
- Whelan, JPF, Hale, JH (1973) Bactericidal activity of metronidazole against Bacteroides fragilis. Journal of Clinical Pathology 26: pp. 393
- Willis, AT (1977) Metronidazole in anaerobic infections. Scottish Medical Journal 22: pp. 155
- Willis, AT, Ferguson, IR, Jones, PH, Phillips, KD, Tearle, PV, Berry, RB, Fiddian, RV, Graham, DF, Harland, DHC, Innes, DB, Mee, WM, Rothwell-Jackson, RL, Sutch, I, Kilbey, C, Edwards, D (1976) Metronidazole in prevention and treatment of Bacteroides infections after appendicectomy. British Medical Journal 1: pp. 318
- Willis, AT, Ferguson, IR, Jones, PH, Phillips, KD, Tearle, PV, Fiddian, RV, Graham, DF, Harland, DHC, Hughes, DFR, Knight, D, Mee, WM, Pashby, N, Rothwell-Jackson, RL (1977) Sachdeva, H.K.; Sutch, I.; Kilbey, C. and Edwards, D.: Metronidazole in prevention and treatment of bacteroides infections in elective colonic surgery. British Medical Journal 1: pp. 607
- Wilson, WR, Martin, WJ, Wilkowske, CJ, Washington, JA (1972) Anaerobic bacteremia. Mayo Clinic Proceedings 47: pp. 639
- Wise, R, Andrews, JM, Bedford, KA (1975) The antimicrobial effect of combinations of clindamycin and metronidazole with spectinomycin. Journal of Antimicrobial Chemotherapy 1: pp. 439
- Wise, R. and Bedford, K.: The activity of eight antimicrobial agents, including three nitroimidazole compounds against 40 clinical isolates of Bacteroides spp. 9th International Congress of Chemotherapy, London (1975).
- Wood, BA, Monro, AM (1975) Pharmacokinetics of tinidazole and metronidazole in women after single oral doses. British Journal of Venereal Diseases 51: pp. 51
- Wren, MWD, Baldwin, AWF, Eldon, CP, Sanderson, PJ (1977) The anaerobic culture of clinical specimens: A 14-month study. Journal of Medical Microbiology 10: pp. 49
- Wust, J (1977) Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardised methods. Antimicrobial Agents and Chemotherapy 11: pp. 631
- Metronidazole in Anaerobic Infections: A Review of its Activity, Pharmacokinetics and Therapeutic Use
Volume 16, Issue 5 , pp 387-417
- Cover Date
- Print ISSN
- Online ISSN
- Springer International Publishing
- Additional Links
- Industry Sectors